Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 156-165

  Bosch, Ralph F ^a   Li, Gui Rong ^b,c   Gaspo, Rania ^b   Nattel, Stanley ^b,c,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; THYROID HORMONE;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE WALL; HORMONAL REGULATION; HYPOTHYROIDISM; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL;

ACTION POTENTIALS; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELL SEPARATION; DELAYED RECTIFIER POTASSIUM CHANNELS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; GUINEA PIGS; HEART RATE; HEART VENTRICLES; HYPOTHYROIDISM; MALE; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 0032893049     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Baiser JR, Bennett PB, Hondeghero LM and Roden DM (1991) Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. Circ Res 69:519-529.
2. Bergman M, Cohen F, Schlesinger H and Kessler-Icekson G (1995) Effects of amiodarone on beating rate and Na-K-ATPase activity in cultured neonatal rat heart myocytes. Gen Pharmacol 26:285-290.
3. Cairns JA, Connolly SJ, Roberts R and Gent M for the Canadian Amiodarone Myocardial Infarction: Arrhythmia Trial Investigators (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349:675-682.
4. Colatsky TJ, Follmer CH and Starmer CF (19901 Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82:2235-2242.
5. Drvota V, Carlsson B, Häggblad J and Sylvén C (1995) Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype β1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect. J Cardiovasc Pharmacol 26:222-226.
6. Finance O, Manning A and Chatelain P (1995) Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, d,l-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardioiasc Pharmacol 26:570-576.
7. Follmer CH, Aomine M., Yeh JZ and Singer DH (1987) Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther 243:187-194.
8. Gallagher JD, Bianchi J and Gessman LJ (1989) A comparison of the electrophysiologic effects of acute and chronic amiodarone administration on canine Purkinje fibers. J Cardiovasc Pharmacol 13:723-729.
9. 2+-channels, nuclear triiodothyronine receptors and triiodothyranine concentration in pig myocardium after long-term low-dose amiodarone treatment. Acta Endocrinol 129:337-347.
10. Gotzsche LBH and Orskov H (1994) Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo-and hyperthyroid rats. Eur J Endocrinol 130:281-290.
11. + pump in rabbit cardiac myocytes after acute and chronic treatment. J Pharmacol Exp Ther 284:75-82.
12. + channel activities of cultured rat cardiomyocytes. J Mol Cell Cardiol 29:617-627.
13. max of action potential in single ventricular myocytes. Br J Pharmacol 102:651-656.
14. Ikeda N, Nademanee K, Kannan R and Singh BN (1984) Electrophysiologic effects of amiodarone: Experimental and clinical observations relative to serum and tissue drug concentrations. Am Heart J 108:890-898.
15. Kamiya K, Cheng J, Kodama I and Toyama J (1995) Modulation of repolarizing potassium channels and Kv1.5 mRNA by long-term treatment with amiodarone (Abstract). Circulation 92:81-373.
16. Kodama I, Kamiya K and Toyama J (1997) Cellular electropharmacology of amiodarone. Cardiovasc Res 35:13-29.
17. Latham, KR, Selliti, DF and Goldstein, RE (1987) Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors. J Am Coll Cardiol 9:872-876.
18. K, in rabbit sino-atrial node cells. Exp Physiol 81:725-741.
19. Link MS, Homoud M, Foote CB, Wang PJ and Estes NAM III (1996) Antiarrhythmic drug therapy for ventricular arrhythmias: Current perspectives. J Cardioiasc Electrophysiol 7:653-670.
20. Liu P, Fei L, Wu W, Li J, Wang J and Zhang X (1996) Effects of hypothyroidism on the vulnerability to ventricular fibrillation in dogs: A comparative study with amiodarone. Cardiovasc Drugs Ther 10:369-378.
21. Manning AS, Bruyninckx C, Ramboux J and Chatelain P (1995b) SR 33589, a new amiodarone-like agent: Effect on ischemia-and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 26:453-461.
22. Manning A, Thisse V, Hodeige D, Richard J, Heyndrickx JP and Chatelain P (1995a) SR 33589, a new amiodarone-like antiarrhythmic agent: Electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 25:252-261.
23. Mason JW, Hondeghem LM and Katzung BG (1984) Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 55:277-285.
24. Mitchell LB, Wyse DG, Gillis AM and Duff HJ (1989) Electropharmacology of amiodarone therapy initiation. Circulation 80:34-42.
25. Nademanee K, Singh BN, Stevenson WG and Weiss JN (1993) Amiodarone and post-MI patients. Circulation 88:764-774.
26. Nattel S (1995) Newer developments in the management of atrial fibrillation. Am Heart J 130:1094 -1106.
27. Nattel S, Talajic M, Quantz M and DeRoode M (1987) Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: Evidence for calcium channel-blocking activity. Circulation 76:442-449.
28. Néliat G, Ducouret P, Moreau M and Gargouil YM (1982) Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil. Arch Int Pharmacodyn 255:237-255.
29. Nishimura M, Follmer CH and Singer DH (1989) Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther 251:650-659.
30. Ohta M, Karagueuzian HS, Mandel WJ and Peter T (1987) Acute and chronic effects of amiodarone on delayed afterdepolarization and triggered automaticity in rabbit ventricular myocardium. Am Heart J 113:289-296.
31. Patterson E, Waiden KH, Khazaeli MB, Montgomery DG and Lucchesi BR (1986) Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: Altered thyroid hormone metabolism. J Pharmacol Exp Ther 239:179-184.
32. Podrid, PJ (1995) Amiodarone: Reevaluation of an old drug. Ann Intern Med 122: 689-700.
33. Raatikainen MJP, Napolitano CA, Druzgala P and Dennis DM (1996) Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart. J Pharmacol Exp Ther 277:1454-1463.
34. Ks. Am J Physiol 271:H2477-H2489.
35. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
36. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
37. Sato R, Koumi SI, Singer DH, Hisatome I, Jia H, Eager S and Wasserstrom JA (1994) Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther 269:1213-1219.
38. Singh, BN (1995) Expanding indications for the use of class III agents in patients at high risk for sudden death. J Cardiovasc Electrophysiol 6:887-900.
39. Singh, BN and Vaughan Williams, EM (1970) The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657-667.
40. Stäubli M and Studer H (1986) The effects of amiodarone on the electrocardiogram of the guinea-pig are not explained by interaction with thyroid hormone metabolism alone. Br J Pharmacol 88:405-410.
41. Talajic M, Nattel S, Davies M and McCans J (1989) Attenuation of class III and sinus node effects of amiodarone by experimental hypothyroidism. J Cardiovasc Phar-macol 13:447-450.
42. Valenzuela C and Bennett PB (1991) Voltage-and use-dependent modulation of calcium channel current in guinea pig ventricular cells by amiodarone and desoxo-amiodarone. J Cardiovasc Pharmacol 17:894-902.
43. Varró A, Virág L and Papp JG (1996) Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br J Pharmacol 117:1181-1186.
44. Venkatesh N, Padbury JF and Singh BN (1986) Effects of amiodarone and desethylamiodarone on rabbit myocardial β-adrenoceptors and serum thyroid hormones-absence of relationship to serum and myocardial drug concentrations. J Cardiovasc Pharmacol 8:989-997.
45. Watanabe Y, Hara Y, Tamagawa M and Nakaya H (1996) Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells. J Pharmacol Exp Ther 279:617-624.
46. Wiegand V, Wagner G and Kreuzer H (1986) Hypothyroid-like effect of amiodarone in the ventricular myocardium of the rat. Basic Res Cardiol 81:482-488.